MedTrace Logo

EUpertstrain 4 Study of Bordetella Pertussis Isolates

NCT03197597 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2017-06-23

No results posted yet for this study

Summary

This study focus on the genetic changes of B. pertussis clinical isolates. For this panels of B. pertussis isolates has been collected during four periods in different European countries.

Conditions

  • Bordetella Pertussis, Whooping Cough

Interventions

OTHER

Strain isolation from the nasopharynx

B. pertussis strains has been collected from the nasopharynx of the patients during the clinical visit

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Sanofi Pasteur, a Sanofi Company

    collaborator INDUSTRY

  • University of Turku

    lead OTHER

Principal Investigators

  • Qiushui He, MD, PhD · University of Turku

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-12
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03197597 on ClinicalTrials.gov